概括
本综述综合了癌症信号通路,提供了一个克服治疗耐药性的新框架. 它将基因组数据与途径动态集成在一起,以改善精确的瘤治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 由于复杂的信号通路,如MAPK,PAM和Wnt/β-catenin,癌症研究面临着挑战.
- 瘤的遗传变化汇聚在核心路径上,但下游分歧,通过EMT引起治疗阻力,免疫逃避和代谢重编程.
研究的目的:
- 将融合和分离的信号通路合成为精密瘤学的临床可操作框架.
- 批判性地评估当前的精确瘤学策略,并确定解决治疗耐药性的差距.
- 提出一个双轴模型,整合基因组分析和动态信号演化,用于精密治疗.
主要方法:
- 文献综述综合了有关癌症信号通路的现有研究.
- 对当前精确瘤学策略及其局限性的批判性评估.
- 开发一种新型的双轴模型,用于精密疗法,由路径动态提供信息.
主要成果:
- 确定了关键癌症信号通路 (MAPK,PAM,Wnt/β-catenin) 的趋同和分歧.
- 治疗耐药性的突出机制包括EMT,免疫逃避和代谢重编程.
- 为临床应用提出了一种双轴模型,将静态基因组数据与动态信号相结合.
结论:
- 一个新的框架合成路径的收和分歧为精确瘤学提供了临床见解.
- 拟议的双轴模型为开发用于克服适应性抗性的组合疗法提供了路线图.
- 未来的研究应该专注于利用途径的相互依赖性和动态信号来提高癌症治疗的有效性.
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Diversity in Cell Signaling Responses
7.7K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...
7.7K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K


